Title of the register

Turkuaz Alzheimer’s Working Group Register

Name of Principal Investigator
TitleMD, PhD
First name
Last nameYener
Address of institution where award is held
Street AddressMithatpasa Cad.
  • Turkey
  • Website


    Contact email
    1. Conditions included, or expected to be included, in the disease register
  • Alzheimer’s disease and other dementias
  • Parkinson’s disease
  • Neurodegenerative disease in general
  • 2a. Stated aim of the cohort

    To pool the patients’ data across Turkey when needed for a clinical dementia study

    2b. Features distinguishing this register from other disease registers

    It is the first and the only web-based dementia registry in Turkey, as far as we know.

    3a. i) Number of publications that involve use of register to date


    3a. ii) Up to three examples of studies to date (PI, Institution, Title of Study)
    1. Name of PI
    4a. Study criteria: age range of participants
    Age in years from:40+
    4b. Study criteria: inclusion criteria

    applying to memory clinics nationwide

    4c. Study criteria: exclusion criteria


    5. Size of the register (i.e. number of patients enrolled)
  • 1,001 – 5,000 clinical cases
  • 6a. Measures used to characterise participants

    To apply or to be referred to dementia outpatient clinics

    6b. Are there defined primary and secondary endpoints (e.g. defined health parameters)
  • No
  • 7a. i) Is the register of fixed duration


    7a. ii) Data collection start date


    7a. iii) Data collection end date


    7b. Stage of data collection/analysis for the register
  • Data collection ongoing
  • 8. Funding of the register
    How the register is fundedBetween 01-06-2006 and 01-04-2011 a drug company Sanovel funded this registry
    Is funding ongoingWe are applying to Turkish Neurological Society
    If so, for how long36 months
    10.The clinical (phenotypic) information held in the register from patients and other participants such as family members is
  • Routinely collected as medical records
  • 11. Limit on the number of studies that can be based on this set of patients
  • No
  • 12a. Data stored in a database
    Yes/No% available
    yeswhen needed
    12b. Data held as individual records
    Yes/No% available
    13a. Are data available to other groups


    13b. Access policy/mechanisms for access if data are available to other groups
  • Resource has own ethics approval so usually no need for separate external ethics approval
  • 14. Data sharing policy specified as a condition of use
  • No requirement to make data publicly available
  • 15a. Are tissues/samples/DNA available to other groups


    15b. i) Description of available tissues/samples/DNA
  • Living donors:blood
  • Living donors: blood derivatives
  • Living donors: DNA
  • 15b. ii) Form available tissues/samples/DNA are supplied in
  • Primary samples: Supplied fresh
  • Primary Samples: Stabilised samples (frozen or fixed)
  • Secondary samples: derivatives of primary samples
  • Secondary samples: plasma
  • Secondary samples: DNA
  • 15b iii) Is the access policy/mechanism for obtaining samples the same as that for obtaining data


    16a. Is information on biological characteristics available to other group
  • No
  • 16b. Is the access policy/mechanism for obtaining details of the characteristics the same as that for obtaining other data


      Types: Disease Registers
      Member States: N/A
      Diseases: N/A
      Years: 2011
      Database Categories: N/A
      Database Tags: N/A

      Export as PDF